Bookmark

Add to MyYahoo RSS

Abbott Labs News

News on Abbott Labs (Ticker: ABT) continually updated from thousands of sources around the net.

12 hrs ago | Money Morning

Tesla (Nasdaq: TSLA) Stock Up After Crushing Earnings; How to Play It Now By Kyle Anderson

As a Money Morning Member, you'll get our top financial news stories delivered straight to your inbox - every weekday morning.

Comment?

Related Topix: Tesla Motors, Startups, Facet Biotech, Absolute Software, Abbott Laboratories, Software

Yesterday | Money Morning

The Important Impact of This "Secret" Agreement By Peter Krauth

As a Money Morning Member, you'll get our top financial news stories delivered straight to your inbox - every weekday morning.

Comment?

Related Topix: Absolute Software, Facet Biotech, Abbott Laboratories, Software

Wed Jul 30, 2014

Hispanic Business

An Application for the Trademark 'Personalized Possibilities' Has Been Filed by Abbott Laboratories

The international trademark goods and services class codes for this trademark application are 035, 042 and 044.

Comment?

Related Topix: Facet Biotech, Absolute Software, Abbott Laboratories, Software, Medicine, Pharmacology, Genetics

Tue Jul 29, 2014

Business Insurance

Abbott Labs' $84M insurance award in claims dispute over obesity drug upheld

An Illinois appeals court has upheld an $84.5 million insurance award to drugmaker Abbott Laboratories in a breach-of-contract claim against several Lloyd's of London syndicate underwriters.

Comment?

Related Topix: Facet Biotech, Absolute Software, Abbott Laboratories, Software

Thu Jul 24, 2014

Bloomberg

Sanofi Drugs Sale Said to Draw Blackstone, KKR Interest

Sanofi 's $8.5 billion portfolio of older, off-patent drugs has drawn interest from private-equity firms KKR & Co., Blackstone Group and TPG Capital, people with knowledge of the matter said.

Comment?

Related Topix: Blackstone Group, Advertising, Facet Biotech, Absolute Software, Abbott Laboratories, Software

Hispanic Business

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And...

Upon closing, Abbott will receive 105 million shares of the combined company worth approximately , representing an approximately 21% ownership stake.

Comment?

Related Topix: Absolute Software, Facet Biotech, Abbott Laboratories, Software

Wed Jul 23, 2014

Hispanic Business

Trademark Application for 'Starlims Fusion' Filed by Abbott Laboratories

The serial number for this application is 85323171. As submitted by the applicant, this trademark application relates to the following goods and services: Software programs specifically for use in research and diagnostic laboratories, in particular to enable data interfacing between laboratory instruments and apparatus and laboratory information ... (more)

Comment?

Related Topix: Facet Biotech, Abbott Laboratories, Absolute Software, Software

Tue Jul 22, 2014

GlobeNewswire

Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories,...

Research and Markets has announced the addition of the "Global IVD Market 2014-2018" report to their offering.

Comment?

Related Topix: Facet Biotech, Abbott Laboratories, Absolute Software, Software, Medicine, Hematology

Mon Jul 21, 2014

TheStreet.com

Will These EPS Estimate Cuts Hurt Abbott Laboratories (ABT) Stock Today?

The analyst firm lowered its EPS estimates for 2015 through 2018 by 7% to 10%. The firm now expects earnings of $2.66 a share in 2015, down from previous estimates of $2.87 a share for the year.

Comment?

Related Topix: Facet Biotech, Absolute Software, Software, Abbott Laboratories, Financial Markets

Sun Jul 20, 2014

Chemical & Engineering News

Tax-Advantaged Pharma Deals Come Under Fire

AbbVie and Abbott, the two Illinois companies formed from the 2012 split of Abbott Laboratories, are both involved in tax-inversion acquisitions being criticized by lawmakers because they would allow U.S. companies to move offshore to pay less tax.

Comment?

Related Topix: US Politics, Barack Obama, US News, US Senate, Democrat, Illinois, Illinois Government

The Motley Fool

Can Abbott Laboratories Stock Continue to Impress?

Spinning off the company's pharmaceutical arm into AbbVie exposed a bloated, underperforming giant.

Comment?

Fri Jul 18, 2014

The Glittering Eye

What Kind of Jobs Do They Want?

Miles White, CEO of Chicago-based Abbott Laboratories, explains corporate inversion , companies' changing of national jurisdictions, frequently seeking tax relief: First, inversion is legal.

Comment?

Related Topix: Facet Biotech, Absolute Software, Abbott Laboratories, Software, Healthcare Law, Law, Agriculture, Science

Forbes.com

Abbott Raises Full Year Earnings Guidance On Strong Q2 Results

Healthcare giant Abbott Laboratories reported a strong set of second quarter 2014 results on Wednesday, July 16. The company's operational sales increased 3% over the prior year quarter to $5.55 billion, beating analysts' estimates of $5.52 billion compiled by Thomson Reuters.

Comment?

Related Topix: Facet Biotech, Absolute Software, Software, Abbott Laboratories, Financial Markets

Thu Jul 17, 2014

FoodNavigator

Abbott making 'progress' repairing Fonterra botulism scare damage

New products gallery: Gen Mills innovates to keep up with trends, Mamma Chia's 'cleaner energy', CVS makes healthy snacks affordable 'Who are you, Mother Teresa?' We are American.

Comment?

Related Topix: Botulism, Health, Beverages, PepsiCo, Facet Biotech, Absolute Software, Abbott Laboratories, Software

AmericanBankingNews.com

Abbott Laboratories Given Outperform Rating at Raymond James

's stock had its "outperform" rating reiterated by Raymond James in a research note issued on Thursday.

Comment?

Related Topix: Facet Biotech, Absolute Software, Abbott Laboratories, Software, Raymond Ltd, Apparel

Wall Street Journal

Sanofi Looking At Options for Older Drug Lines

French drug maker Sanofi SA has held talks with private-equity firms and rivals including Abbott Laboratories over a potential sale of a set of older drugs valued at 6.3 billion euros , according to a Sanofi document reviewed by The Wall Street Journal.

Comment?

Related Topix: Absolute Software, Facet Biotech, Abbott Laboratories, Software

Investor's Business Daily

Abbott, St. Jude Top Views, But Stocks Under Pressure

Medical product giants St. Jude Medical and Abbott Laboratories both beat analysts' Q2 expectations and raised their guidance Wednesday, but their shares had a bumpy ride on the market amid a fresh attack on drug-industry mergers.

Comment?

Related Topix: Medicine, Medical Equipment, Healthcare Industry, St Jude Medical, Financial Markets, Facet Biotech, Absolute Software, Abbott Laboratories, Software

Seeking Alpha

Abbott Laboratories' (ABT) CEO, Miles White on Q2 2014 Results - Earnings Call Transcript

Good morning and thank you for standing by. Welcome to Abbott's Second Quarter 2014 Earnings conference call.

Comment?

Related Topix: Abbott Laboratories

Wed Jul 16, 2014

Hispanic Business

An Application for the Trademark 'ACCELERATOR P540' Has Been Filed by Abbott Laboratories

The international trademark goods and services class code for this trademark application is 009.

Comment?

Related Topix: Facet Biotech, Absolute Software, Software, Abbott Laboratories, Computers

The Washington Post

Abbott's Asset Sale Provides Ammunition for Perrigo: Real M&A

Free from an underperforming unit, Abbott Laboratories is positioned to go after potential targets from Insulet Corp. to Perrigo Co.

Comment?

Related Topix: Facet Biotech, Abbott Laboratories, Medicine, Diabetes, Health, Volcano, Healthcare Industry, RBC Financial Group, Banking, Financial Services

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••